UPL Limited has filed its quarterly monitoring agency report for the period ended December 31, 2025, detailing the utilization of proceeds from its rights issue worth ₹3,377.74 crore. The report, submitted to BSE and NSE on February 2, 2026, confirms compliance with regulatory requirements under SEBI regulations.

Rights Issue Utilization Overview

The monitoring agency report, prepared by CARE Ratings Limited, reveals that UPL utilized ₹74.8 crore during Q3 FY26 from its rights issue proceeds. The funds were primarily deployed for working capital vendor payments as part of the company's general corporate purposes allocation.

Object-wise Fund Deployment

The rights issue proceeds were allocated across three primary objectives, with the majority earmarked for debt reduction. The company has made substantial progress in utilizing funds according to the original plan outlined in the offer document.

Debt Repayment Progress

The largest allocation of ₹3,008.8 crore was designated for prepayment and redemption of outstanding borrowings. As of December 31, 2025, the company had utilized ₹2,989.7 crore for this purpose, with no additional deployment during Q3 FY26. This represents near-complete utilization of the allocated amount for debt reduction.

General Corporate Purposes

Under the general corporate purposes category, UPL allocated ₹337.8 crore, of which ₹332.2 crore has been utilized cumulatively. During Q3 FY26, the company deployed ₹74.8 crore specifically for working capital vendor payments, demonstrating active use of funds for operational requirements.

Compliance and Monitoring

The monitoring agency confirmed no deviations from the disclosed objects of the issue, with all utilization proceeding as per the offer document. CARE Ratings Limited verified the deployment through chartered accountant certificates, bank statements, and management certifications from Vora & Associates.

Unutilized Funds Management

The remaining ₹13.3 crore of unutilized proceeds is maintained in designated accounts, including ₹8.1 crore in the allotment account and ₹5.2 crore in the partly paid-up rights share account. The monitoring agency noted no delays in implementation of the stated objects, with all activities progressing according to the FY27 completion timeline.

Regulatory Framework

The report was submitted in compliance with Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Regulation 82(4) of SEBI (Issue of Capital and Disclosure Requirement) Regulations, 2018. The company confirmed that detailed information is available on its investor relations website for stakeholder reference.

UPL Limited has submitted its investor presentation for Q3 and nine months FY2026 to BSE Limited and National Stock Exchange of India under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation covers consolidated financial results and business updates for the quarter and nine months period ended December 31, 2025.

Regulatory Compliance and Filing Details

The company filed the investor presentation on February 2, 2026, through Company Secretary and Compliance Officer Sandeep Deshmukh. The submission was made to multiple exchanges including BSE (Scrip Code: 512070), NSE (Symbol: UPL), London Stock Exchange, and Singapore Stock Exchange, ensuring comprehensive regulatory compliance across all listing jurisdictions.

Presentation Structure and Content

The comprehensive investor presentation includes detailed financial and business segment analysis, covering key macro trends, performance updates, and platform-wise business reviews. The document provides extensive coverage of revenue analysis, contribution margins, EBITDA performance, and balance sheet metrics across UPL's diversified business platforms.

Forward-Looking Statements and Risk Factors

The presentation contains forward-looking statements regarding UPL's financial condition, results of operations, and business plans. The company has included comprehensive disclaimers highlighting various risk factors including domestic and global economic conditions, regulatory changes, exchange rate fluctuations, and industry competition that could impact actual results.

The investor presentation serves as a comprehensive resource for stakeholders to understand UPL's quarterly performance and strategic direction, providing detailed insights into the company's diversified agrochemical and seeds business operations across global markets.